[Attention deficit syndrome in adults: clinical, psychophysiological features and treatment].
The authors present the results of examination of 34 patients, aged from 18 to 30 years, with attention deficit hyperactivity disorder (ADHD) (ICD-10 item F90.0). The study has shown that inattentive type of ADHD is noted in 50%, combined type in 38.3% and hyperactivity/impulsivity type in 11.7% of patients. Adult patients with ADHD also have a high level of anxiety and asthenic disorders. This study evaluated the efficacy and safety of adaptol in dosage 1500 mg daily during 8 weeks in the treatment of this group of patients. The high efficacy (improvement in 64,7% of cases) and safety of adaptol confirmed by the data of clinical, psychological and neurophysiological studies.
Institut mozga cheloveka im. N.P. Bekhterevoĭ Rossiĭskoĭ akademii nauk, Sankt-Peterburg.
L S
LS
Chutko
S Iu
SIu
Surushkina
E A
EA
Iakovenko
I S
IS
Nikishena
T I
TI
Anisimova
D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use; D001288:Attention; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000523:psychology*; D001736:Biureas / Q000008:administration & dosage / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D006801:Humans; D007175:Impulsive Behavior / Q000188:drug therapy; D011603:Psychophysiology; D013577:Syndrome; D016896:Treatment Outcome; D055815:Young Adult
D014151:Anti-Anxiety Agents; D001736:Biureas; C015979:mebikar